Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide + dexamethasone salvage treatment in relapsed/refractory mantle cell lymphoma
2008-000044-14Phase 2Completed
- Sponsor
- Fondazione Italiana Linfomi
- Start
- Nov 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lenalidomide and dexamethasone in mantle cell lymphoma (MCL), sponsored by Fondazione Italiana Linfomi. Primary endpoint: Overall response rate. Started Nov 2008; status: completed.
02
Drugs
lenalidomidedexamethasone
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on 2008-000044-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000044-14.